Download HO Chi Lui, Paul

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript 
Name: Paul Chi Lui Ho
Designation: Professor
Office Address: Department of Pharmacy,
NUS, 18 Science Drive 4, Singapore 117543
Contact details:
Tel. 65162651; email. [email protected]
MAJOR RESEARCH INTERESTS
-preclinical and clinical pharmacokinetic study
-nanomedicines for cancer and neurodegenerative diseases
-
SELECTED PUBLICATIONS
1.
Wang, Z, W K Chui and P C L Ho*, "Nanoparticulate Delivery System Targeted to Tumor Neovasculature for Combined Anticancer and Antiangiogenesis Therapy." Pharmaceutical Research, 28, no. 3 (2011): 585‐596. (Germany). (Cover page). 2. Wang, Z and P C L Ho*, "Self‐assembled core‐shell vascular‐targeted nanocapsules for temporal antivasculature and anticancer activities." Small, 6, no. 22 (2010): 2576‐
2583. (Germany). 3. Wang, Z and P C L Ho*, "A nanocapsular combinatorial sequential drug delivery system for antiangiogenesis and anticancer activities" Biomaterials, 31, no. 27 (2010): 7115‐
7123. (United Kingdom). 4. Wang, Z, W K Chui and P C L Ho*, "Integrin targeted drug and gene delivery". Expert Opinion on Drug Delivery, 7, no. 2 (2010): 159‐171. (United Kingdom). 5. Ho, P C L, "Combined chemotherapy delivered by nanoparticulate systems: an old concept with modern innovations." Therapeutic Delivery, 3, no. 12 (2012): 1363‐
1368. (United Kingdom). 6. Wang, J, Z WANG, K P Loh*, Y YAN, Y L ZHONG, Q.‐H. XU and P C L Ho, "Fluorescent Nanogel of Arsenic Sulfide Nanoclusters". Angewandte Chemie‐International Edition, 48, no. 34 (2009): 6282‐6285, 6282. (Germany). 7.
Su*, J, LI He, N Zhang and P C L Ho*, "Evaluation of tributyrin lipid emulsion with
affinity to low density lipoprotein: Pharmacokinetics in adult male Wistar rats and
cellular activity on Caco -2 and HepG2 cell lines". Journal of Pharmacology and
Experimental Therapeutics, 316, no. 1 (2006): 62-70. (United States).
8.
Wang*, Z, T Y LEE and P C L Ho*, "A novel dextran‐oleate‐cRGDfK conjugate for self‐
assembly of nanodrug". Nanomedicine: Nanotechnology, Biology and Medicine, 8, no. 2 (2012): 194‐203. (United States). 9.
Surajit, D, KY Ng* and P C L Ho*, "Design of a pectin‐based microparticle formulation using zinc ions as the cross‐linking agent and glutaraldehyde as the hardening agent for colonic‐specific delivery of resveratrol: In vitro and in vivo evaluations." Journal of Drug Targeting, 19, no. 6 (2011): 446‐457. (United Kingdom). 10.
Kong, S T, HS Lin, J H Ching and P C L Ho*, "Evaluation of dried blood spots (DBS) as sample matrix for gas chromatography ‐ mass spectrometry (GC‐MS) based metabolomic profiling". Analytical Chemistry, 83, no. 11 (2011): 4314‐4318. (United States).
Related documents